ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Zeo ScientifiX, Inc.
Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026
- Market cap
- $7.08M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.0875 (−54.37%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Zeo ScientifiX, Inc. reported revenue of $6.99M for the twelve months to Apr 30, 2026. Free cash flow was -$741.00K.
Revenue
$6.99M
TTM Q2 2026
Operating income
-$4.13M
TTM Q2 2026
Free cash flow
-$741.00K
FY2025
EPS, diluted
-$0.58
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Apr 30, 2026
Valuation
- Market cap
- $7.08M
- P/E ratio
- –
- Price to sales
- 1.01
- Price to book
- 9.94
- Dividend yield
- –
- Free cash flow yield
- -10.47%
Fundamentals
- Revenue
- $6.99M
- Net income
- -$3.88M
- EPS, diluted
- -$0.58
- Free cash flow
- -$741.00K
- Book value per share
- $0.09
- Diluted shares
- 8M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$6.99M
Gross profit
$5.70M
Operating income
-$4.13M
Net income
-$3.88M
EPS, diluted
-$0.58
Free cash flow
–
Reported periodTrailing twelve months